L Monno
Overview
Explore the profile of L Monno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
463
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bavaro D, Diella L, Fabrizio C, Sulpasso R, Bottalico I, Calamo A, et al.
Int J Infect Dis
. 2021 Mar;
105:709-715.
PMID: 33722685
Background: The spectrum of COVID-19 clinical manifestations is not yet known. In the elderly, mortality and extrapulmonary involvement appears more frequent than expected. Methods: A multicentre-retrospective-case-series study of COVID-19 patients,...
2.
Di Gennaro F, Marotta C, Pisani L, Veronese N, Pisani V, Lippolis V, et al.
Epidemiol Infect
. 2020 Feb;
148:e40.
PMID: 32102721
Sierra Leone is the country with highest maternal mortality and infections are the underlying cause in 11% of maternal deaths, but the real burden remains unknown. This study aims to...
3.
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients
Ungaro R, Taramasso L, Bruzzone B, Vicenti I, Galli L, Borghi V, et al.
Clin Microbiol Infect
. 2019 Jul;
25(11):1443-1446.
PMID: 31352080
No abstract available.
4.
Bavaro D, Calamo A, Lepore L, Fabrizio C, Saracino A, Angarano G, et al.
Infection
. 2019 Jan;
47(3):441-446.
PMID: 30649685
Purpose: We aimed to evaluate HIV-1 compartmentalization between the cerebrospinal fluid (CSF) and plasma and investigate as to which extent HIV-1 strains in CSF differ from those in blood and...
5.
Evolution of HIV-1 transmitted drug resistance in Italy in the 2007-2014 period: A weighted analysis
Franzetti M, De Luca A, Ceccherini-Silberstein F, Spagnuolo V, Nicastri E, Mussini C, et al.
J Clin Virol
. 2018 Aug;
106:49-52.
PMID: 30075459
Background: Recent studies suggest that transmitted drug resistance (TDR) may be decreasing in latest years, likely because of the reduced frequency of acquired resistance. However, specific risk factors, geographical areas...
6.
Rusconi S, Adorni F, Tau P, Borghi V, Pecorari M, Maserati R, et al.
J Clin Virol
. 2018 Jun;
105:112-117.
PMID: 29957545
Background: Dolutegravir (DTG) is a next-generation HIV integrase inhibitor (INI) with an increased genetic barrier to resistance with respect to raltegravir (RAL) or elvitegravir (EVG). Few data are available on...
7.
Rossetti B, Di Giambenedetto S, Torti C, Postorino M, Punzi G, Saladini F, et al.
HIV Med
. 2018 Jun;
19(9):619-628.
PMID: 29932313
Objectives: The aim was to evaluate the evolution of transmitted HIV-1 drug resistance (TDR) prevalence in antiretroviral therapy (ART)-naïve patients from 2006 to 2016. Methods: HIV-1 sequences were retrieved from...
8.
Monno L, Saracino A, Scudeller L, Santoro C, Brindicci G, Punzi G, et al.
HIV Med
. 2017 Apr;
18(10):711-723.
PMID: 28444818
Objectives: We assessed whether changes in community viral load (CVL) over time were associated with the rate of new HIV diagnoses (NDs). Methods: HIV-1-positive individuals referred to our institute and...
9.
Saracino A, Bruno G, Scudeller L, Ladisa N, de Gennaro N, Allegrini M, et al.
J Clin Virol
. 2016 Jul;
81:94-9.
PMID: 27371888
Background: In HIV-HCV co-infected patients, the long-term effects of HCV eradication on HIV disease progression are still unclear. Objectives: This study aims to determine if CD4 and CD4/CD8 ratio slopes...
10.
Saracino A, Lorenzini P, Caputo S, Girardi E, Castelli F, Bonfanti P, et al.
Clin Microbiol Infect
. 2015 Nov;
22(3):288.e1-8.
PMID: 26551839
Migrant and Italian HIV-infected patients (n = 5773) enrolled in the ICONA cohort in 2004-2014 were compared for disparities in access to an initial antiretroviral regimen and/or risk of virologic...